Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-24 Sale |
2025-01-27 6:15 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
22,258 | $0.4535 | $10,094 | 490,980 (Direct) |
View |
| 2024-10-07 Sale |
2024-10-08 4:44 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
67,695 | $0.5662 | $38,329 | 452,060 (Direct) |
View |
| 2024-09-09 Sale |
2024-09-11 4:01 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
2,642 | $0.6577 | $1,738 | 289,110 (Direct) |
View |
| 2024-03-11 Sale |
2024-03-11 5:19 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
15,409 | $0.882 | $13,591 | 291,752 (Direct) |
View |
| 2024-02-12 Sale |
2024-02-12 5:23 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
3,683 | $1.007 | $3,709 | 307,161 (Direct) |
View |
| 2023-11-01 Sale |
2023-11-03 4:40 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
67,695 | $0.73 | $49,417 | 310,844 (Direct) |
View |
| 2023-09-08 Sale |
2023-09-12 4:04 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
2,642 | $1.249 | $3,300 | 147,894 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-05 4:05 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
464 | $1.89 | $877 | 150,536 (Direct) |
View |
| 2023-06-23 Sale |
2023-06-26 4:15 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
857 | $1.93 | $1,654 | 151,000 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 4:24 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
857 | $2.23 | $1,911 | 151,857 (Direct) |
View |
| 2023-03-10 Sale |
2023-03-13 4:52 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
18,192 | $0.84 | $15,281 | 152,714 (Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 5:13 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
4,348 | $0.93 | $4,044 | 170,906 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 1:07 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,713 | $0 | $0 | 177,896 (Direct) |
View |
| 2022-06-30 Sale |
2022-07-01 4:56 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,578 | $0 | $0 | 179,609 (Direct) |
View |
| 2022-06-24 Sale |
2022-06-27 4:09 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
856 | $0 | $0 | 181,187 (Direct) |
View |
| 2022-06-16 Sale |
2022-06-17 4:21 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
856 | $0 | $0 | 182,043 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 4:22 pm |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
12,545 | $0 | $0 | 77,899 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
650,000 | $0 | 1,140,980 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-27 6:15 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
61,178 | $0 | 490,980 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-08 4:44 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
230,645 | $0 | 452,060 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-16 5:09 pm |
N/A 2034-02-13 |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
428,248 | $0 | 428,248 (Direct) |
View |
| 2023-10-31 Option Award |
2023-11-02 4:55 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
230,645 | $0 | 378,539 (Direct) |
View |
| 2022-11-07 Option Award |
2022-11-09 4:23 pm |
N/A 2032-11-07 |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
1,350,000 | $0 | 1,350,000 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-01 4:16 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
105,000 | $0 | 182,899 (Direct) |
View |
| 2021-09-08 Option Award |
2021-09-10 4:10 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
27,000 | $0 | 90,444 (Direct) |
View |
Ownership |
2021-09-10 4:08 pm |
N/A N/A |
X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer |
0 | $0 | 131,161 (Direct) |
View |